Abu dhabi: Mubadala Bio has announced the launch of new hemodialysis products through its subsidiary Wellpharma, one of its Abu Dhabi-based manufacturing facilities. This milestone marks the first time hemodialysis concentrate solutions are being manufactured locally in the UAE.
According to Emirates News Agency, the launch introduces eight hospital-grade hemodialysis solutions designed to support dialysis procedures for patients with kidney failure. Hemodialysis is a life-sustaining treatment used when the kidneys are no longer able to effectively filter toxins and excess fluids from the blood. During the procedure, dialysis solutions play a critical role in helping restore electrolyte balance and remove waste products from the bloodstream.
Dr. Bakheet Al Katheeri, CEO of Mubadala's UAE Investments Platform and Chairman of Mubadala Bio, stated that since the launch of Mubadala Bio in 2025, the company has made progress in advancing capabilities across the life sciences sector. The introduction of locally manufactured hemodialysis solutions is an important milestone, considering their critical role within the healthcare ecosystem. Mubadala Bio remains committed to supporting the development of strategic healthcare capabilities and strengthening access to essential medical products.
Dr. Essam Mohamed, Group CEO of Mubadala Bio, emphasized that the launch is a significant milestone for both the company and the wider healthcare sector in the UAE. By producing these solutions locally, they ensure a more consistent supply of critical therapies for patients dependent on dialysis treatments, while reinforcing capabilities in the production of essential hospital-based therapies.
Hamad Almarzooqi, Group Deputy CEO of Mubadala Bio, highlighted that strengthening local manufacturing capabilities supports Abu Dhabi and the UAE's ambition to become a leading hub for life sciences. Building a globally competitive sector requires strong domestic capabilities across the pharmaceutical value chain. The launch of locally manufactured hemodialysis solutions is an important step in advancing these capabilities.